NIH-funded research R01 grant

Immune changes and nerve growth factor problems linked to Alzheimer’s in adults with Down syndrome

Official title: The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome

Funded at University of California-Irvine · NIH-11382738 · Data updated 2026-11-12

Researchers are looking at how immune system changes and problems with nerve growth factor relate to Alzheimer’s in adults with Down syndrome.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California-Irvine
NIH-funded
Lab location1 site (Irvine, United States)
Project startAugust 15, 2024
Project endJuly 31, 2029
Funding year2025
Award (this year)$259,200
NIH project number3R01AG087280-02S1
Project IDNIH-11382738 on NIH RePORTER

Who could benefit from this research

Could help

Adults with Down syndrome, especially those in middle age or showing early cognitive changes, would be the best fit.

Less likely to help

People without Down syndrome or those with very advanced dementia are unlikely to directly benefit from this specific project.

What this research studies

If you have Down syndrome, this project will compare people at different stages of brain changes to find biological signs tied to Alzheimer’s, focusing on immune signals and nerve growth factor (NGF). The team will use samples and data from adults with Down syndrome and partner centers to look for biomarkers inside and outside the usual amyloid/tau framework. Findings could help spot early changes that come before symptoms and point to new prevention approaches. The work builds on existing collaborations among several hospitals and research centers to combine expertise and patient resources.

Why it matters

Potential benefit: This work could help detect Alzheimer’s earlier in people with Down syndrome and point to new targets to prevent or slow decline.

How similar studies have gone: Previous research has documented Alzheimer-like pathology in Down syndrome and biomarker work is active, but the combined focus on immune dysregulation and NGF is relatively new.

Where this research is happening

  • University of California-Irvine
    Irvine, United States
    Active

Researchers

  • Principal investigator: Busciglio, Jorge a — University of California-Irvine
  • Study coordinator: Busciglio, Jorge a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.